BeOne Medicines AG (ONC) earnings: date, estimates, results and stock reactions
Over the last 12 reports the stock moved 4.4% on average (either way), rising 6 times and falling 6. EPS beat estimates 7 of 10 times; revenue 5 of 8. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-05 | 4.59 | 2.34 | +96.2% | 1.89B | 1.75B | +7.7% |
| Q2 FY2026 | 2026-08-05 | 2.05 | 1.63 | +25.8% | 1.71B | 1.62B | +2.1% |
| Q1 FY2026 | 2026-05-06 | 1.96 | 0.73 | +168.5% | 1.51B | 1.44B | +6.6% |
| Q4 FY2025 | 2026-02-26 | 0.58 | 1.60 | -63.8% | 1.50B | 1.47B | -10.0% |
| Q3 FY2025 | 2025-11-06 | 1.09 | 0.72 | +51.4% | 1.41B | 1.45B | -0.4% |
| Q2 FY2025 | 2025-08-06 | 0.84 | 0.48 | +75.0% | 1.32B | 1.44B | -2.9% |
| Q1 FY2025 | 2025-05-07 | 1.22 | -0.71 | +271.8% | 1.12B | 1.25B | -2.4% |
| Q4 FY2024 | 2025-02-27 | -1.43 | -0.88 | -62.5% | 1.13B | 1.04B | +4.9% |